In summary our data shows, for the first time, that neutralization of endogenous IL-22 after onset of arthritis is associated with reduction in the severity of arthritis and administration of anti-IL-22 prior to onset of arthritis results in increased incidence and severity of arthritis. Here, IL22 is linked to arthritic joint disease.